Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases

Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases

Abstract Approximately 30% of individuals with severe SARS-CoV-2 infections also develop neurological and psychiatric complaints. In rare cases, the occurrence of autoimmune encephalitis has been reported after SARS-CoV-2 infection. In this systematic review, we have identified eight SARS-CoV-2-asso...

Descrición completa

Detalles Bibliográficos
Main Authors: Veronika Vasilevska, Paul C. Guest, Hans-Gert Bernstein, Matthias L. Schroeter, Christian Geis, Johann Steiner
Formato: Artigo
Idioma:English
Publicado: BMC 2021-10-01
Series:Journal of Neuroinflammation
Subjects:
SARS-CoV-2
COVID-19
Inflammation
Autoimmune encephalitis
NMDA receptor
Corticosteroid
Acceso en liña:https://doi.org/10.1186/s12974-021-02293-x

Internet

https://doi.org/10.1186/s12974-021-02293-x

Títulos similares